These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 32654557)

  • 1. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
    Son M; Seo J; Yang S
    Hypertension; 2020 Sep; 76(3):742-749. PubMed ID: 32654557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients.
    Pan W; Zhang J; Wang M; Ye J; Xu Y; Shen B; He H; Wang Z; Ye D; Zhao M; Luo Z; Liu M; Zhang P; Gu J; Liu M; Li D; Liu J; Wan J
    Hypertension; 2020 Sep; 76(3):732-741. PubMed ID: 32654555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on association between exposure to renin-angiotensin-aldosterone system inhibitors and coronavirus disease 2019 in South Korea.
    Seo J; Son M
    Korean J Intern Med; 2021 Mar; 36(Suppl 1):S114-S122. PubMed ID: 32872736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
    de Abajo FJ; Rodríguez-Martín S; Lerma V; Mejía-Abril G; Aguilar M; García-Luque A; Laredo L; Laosa O; Centeno-Soto GA; Ángeles Gálvez M; Puerro M; González-Rojano E; Pedraza L; de Pablo I; Abad-Santos F; Rodríguez-Mañas L; Gil M; Tobías A; Rodríguez-Miguel A; Rodríguez-Puyol D;
    Lancet; 2020 May; 395(10238):1705-1714. PubMed ID: 32416785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
    Reynolds HR; Adhikari S; Pulgarin C; Troxel AB; Iturrate E; Johnson SB; Hausvater A; Newman JD; Berger JS; Bangalore S; Katz SD; Fishman GI; Kunichoff D; Chen Y; Ogedegbe G; Hochman JS
    N Engl J Med; 2020 Jun; 382(25):2441-2448. PubMed ID: 32356628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
    Cadegiani FA; Goren A; Wambier CG
    Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
    Dworakowska D; Grossman AB
    J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.
    Mancia G; Rea F; Ludergnani M; Apolone G; Corrao G
    N Engl J Med; 2020 Jun; 382(25):2431-2440. PubMed ID: 32356627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
    Şenkal N; Meral R; Medetalibeyoğlu A; Konyaoğlu H; Kose M; Tukek T
    Anatol J Cardiol; 2020 Jul; 24(1):21-29. PubMed ID: 32628137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension.
    Chen R; Yang J; Gao X; Ding X; Yang Y; Shen Y; He C; Xiang H; Ke J; Yuan F; Cheng R; Lv H; Li P; Zhang L; Liu C; Tan H; Huang L
    J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1974-1983. PubMed ID: 33006442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin-aldosterone system and COVID-19 infection.
    Alexandre J; Cracowski JL; Richard V; Bouhanick B;
    Ann Endocrinol (Paris); 2020 Jun; 81(2-3):63-67. PubMed ID: 32370986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service.
    Kim J; Kim DW; Kim KI; Kim HB; Kim JH; Lee YG; Byeon KH; Cheong HK;
    J Korean Med Sci; 2020 Jun; 35(25):e232. PubMed ID: 32597045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study.
    Jung SY; Choi JC; You SH; Kim WY
    Clin Infect Dis; 2020 Nov; 71(16):2121-2128. PubMed ID: 32442285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension.
    Lee J; Jo SJ; Cho Y; Lee JH; Oh IY; Park JJ; Cho YS; Choi DJ
    Korean J Intern Med; 2021 Mar; 36(Suppl 1):S123-S131. PubMed ID: 32872731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis.
    Ssentongo AE; Ssentongo P; Heilbrunn ES; Lekoubou A; Du P; Liao D; Oh JS; Chinchilli VM
    Open Heart; 2020 Nov; 7(2):. PubMed ID: 33154144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review and Meta-Analysis.
    Chan CK; Huang YS; Liao HW; Tsai IJ; Sun CY; Pan HC; Chueh JS; Wang JT; Wu VC; Chu TS;
    Hypertension; 2020 Nov; 76(5):1563-1571. PubMed ID: 32869673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.
    Usman MS; Siddiqi TJ; Khan MS; Ahmed A; Ali SS; Michos ED; Hall ME; Krasuski RA; Greene SJ; Butler J; Alkhouli M
    Am J Cardiol; 2020 Sep; 130():159-161. PubMed ID: 32624189
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study.
    Bae JH; Choi SK; Kim NH; Lee J; Kim SG
    Diabetes Metab J; 2021 May; 45(3):430-438. PubMed ID: 33611884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.
    Vázquez-Cornejo E
    Bol Med Hosp Infant Mex; 2020; 77(5):274-281. PubMed ID: 33064690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.
    Wong SY; Brubaker AL; Wang AX; Taiwo AA; Melcher ML
    Clin Transplant; 2020 Jul; 34(7):e13991. PubMed ID: 32446267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.